Literature DB >> 6801137

Interaction of very low density lipoproteins (VLDL) with rabbit C-reactive protein.

V G Cabana, H Gewurz, J N Siegel.   

Abstract

Rabbit CRP is similar to human CRP in structure, kinetics of appearance, and binding reactivities to phosphate esters and cationic polymers. CRP in rabbit acute-phase serum migrates either with gamma or with beta, pre-beta electrophoretic mobility, and distinct gamma- and beta-migrating species can be observed simultaneously in some sera. The present study shows that beta-CRP in serum is converted to gamma mobility during isolation and purification. Normal, acute-phase, or CRP-depleted acute-phase rabbit serum restores the beta mobility of purified gamma-CRP, a conversion that does not occur in the presence of EDTA. Serum CRP fails to adsorb to DEAE-cellulose but does adsorb to CM-cellulose, from which it elutes as gamma-mobility antigen. Chelation by EDTA or flotation and removal of lipoproteins from acute phase rabbit serum produces a gamma-mobility CRP that adsorbs to the anion-exchange resin. Lipid-containing fractions from ion-exchange columns as well as VLDL (but not LDL or HDL) isolated by ultracentrifugation change the mobility of purified CRP from gamma to beta, pre-beta. These changes in mobility are not observed in the presence of EDTA or phosphocholine. In acute-phase rabbit serum with CRP of both beta and gamma mobility, the beta form has a higher m.w. and is lipid-associated, whereas the gamma form is a lower m.w., lipid-poor molecule. These results suggest that in serum the association of CRP with lipoproteins, particularly VLDL, is responsible for its beta, pre-beta electrophoretic mobility. Further studies of the association of CRP with lipoprotein in relation to lipoprotein metabolism may provide insight into the biological role of CRP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801137

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  C-reactive protein, inflammation, and innate immunity.

Authors:  R F Mortensen
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Comparison of the enzymatic sensitivities of the platelet receptor for human C-reactive protein and its functional relationship to the platelet IgG Fc receptor.

Authors:  B A Fiedel; J N Siegel; H Gewurz; R M Simpson; J M Izzi
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

3.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

Authors:  B J Van Lenten; S Y Hama; F C de Beer; D M Stafforini; T M McIntyre; S M Prescott; B N La Du; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Atherosclerosis-related functions of C-reactive protein.

Authors:  Alok Agrawal; David J Hammond; Sanjay K Singh
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-12-01

5.  C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy.

Authors:  M J Ridley; D S Ridley; F C De Beer; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

Review 6.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

7.  Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters.

Authors:  I Hardardóttir; S T Kunitake; A H Moser; W T Doerrler; J H Rapp; C Grünfeld; K R Feingold
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species.

Authors:  S C Ying; J J Marchalonis; A T Gewurz; J N Siegel; H Jiang; B E Gewurz; H Gewurz
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

9.  A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins.

Authors:  C M Kinoshita; A T Gewurz; J N Siegel; S C Ying; T E Hugli; J E Coe; R K Gupta; R Huckman; H Gewurz
Journal:  Protein Sci       Date:  1992-06       Impact factor: 6.725

Review 10.  Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP.

Authors:  Sean P Mazer; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.